Skip header and navigation

1 records – page 1 of 1.

Atenolol vs nonatenolol ß-blockers for the treatment of hypertension: a meta-analysis.

https://arctichealth.org/en/permalink/ahliterature104462
Source
Can J Cardiol. 2014 May;30(5 Suppl):S47-53
Publication Type
Article
Date
May-2014
Author
Laura M Kuyper
Nadia A Khan
Author Affiliation
Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Source
Can J Cardiol. 2014 May;30(5 Suppl):S47-53
Date
May-2014
Language
English
Publication Type
Article
Keywords
Adrenergic beta-Antagonists - administration & dosage - adverse effects - pharmacology
Age Factors
Aged
Atenolol - administration & dosage - adverse effects - pharmacology
Calcium Channel Blockers - administration & dosage - adverse effects - pharmacology
Canada
Humans
Hypertension - complications - diagnosis - drug therapy
Incidence
Middle Aged
Prognosis
Randomized Controlled Trials as Topic
Risk assessment
Stroke - epidemiology - etiology - physiopathology
Treatment Outcome
Abstract
Previous reviews have shown that ß-blocker use for the treatment of hypertension without compelling indications was associated with increased risk of stroke in the elderly. It remains unclear whether this increased risk was driven by the type of ß-blocker. We sought to compare the efficacy of atenolol vs nonatenolol ß-blockers in clinical trials enrolling young (
PubMed ID
24750981 View in PubMed
Less detail